The new laboratories at Foss Eikeland have been completed. Biosynth is, with this, adding capacity for larger volumes of anthocyanins. The company is now ready for expanding the number of novel applications for its molecules.

Foss Eikeland is located close to the international airport in Stavanger on the west coast of Norway.

Biosynth have, together with the Swiss company Solvias AG, finished the first phase of upscaling of the syntetic anthocyanin molecules. Solvias is a wold leader in contract research development and upscaling (CRO/CDMO).

The process will be implemented at the new facility at Foss Eikeland.